Navigation Links
Extra hormone found to cut appetite by a third

Studies done previously have shown that the hormone could suppress the appetites of lean people. But researchers were worried it would not work in obese people because studies of another appetite-suppressing hormone,// leptin, had proved disappointing.

"We had to do a second trial to see if obese people were as sensitive" to the hormone, said researchers. The answer: "Yes, they are. They're just as sensitive as thin people."

In a small study done , both obese and lean people ate about 30 percent less from a buffet lunch after they were given a dose of the hormone, PYY3-36, to trick the brain into thinking they had already eaten. The research also showed lower natural levels of PYY in the obese, which may explain why they are hungrier and overeat.

However researchers say long-term use of the hormone would have to be studied before it could be developed into a treatment for obesity that would consist of injections given before meals. "We haven't yet shown you get actual weight reduction. We've only shown you eat less," researchers said.

The findings could also point to a more natural treatment for obesity: A high-fiber diet is believed to boost the body's production of PYY.

The PYY hormone, one of a number of hormones that stimulate or suppress hunger, is released by the gut as you eat. It tells the part of the brain that controls appetite when you are full. Dr. Rudolph L. Leibel, an obesity researcher , said it is unlikely that PYY alone will turn out to be the "magic bullet" against obesity, but it may prove useful in combination with other drugs. He said the body has backup systems that kick in to resist the loss of body fat -- the reason so many people who lose weight gain it back.

"We can't fool Mother Nature yet," he said. Currently, there are only a few prescription weight-control drugs, and they produce only modest weight loss. They work by suppressing the appetite through a brain chemical or by blockin g fat from being absorbed.

The British researchers recruited 24 people: 12 obese and 12 lean. Their food consumption was monitored twice, once after an intravenous dose of synthetic PYY and once after getting a harmless saline solution. Two hours later, they were given a large buffet lunch.

After the PYY dose, the obese ate 30 percent fewer calories than they did after the dummy solution. The lean people ate 31 percent less. The PYY continued to curb their appetites for 12 hours, with the obese eating 26 percent less and the lean eating about 34 percent less, based on food diaries they kept.

The PYY did not affect food consumption from 12 hours to 24 hours after the infusion. Without the extra dose, PYY levels were lower in the obese participants than in the lean, but the researchers said it is not known whether that is a cause of obesity or a consequence.

If it's a consequence of obesity, it would explain why once people become overweight, it is very difficult for them to reverse it. They don't feel as feel as full after food as normal people do as a result of their obesity.
'"/>




Related medicine news :

1. Is Drinking Extra Fluids Safe When You’re Sick
2. Extracts of grapefruit heals stomach ulcers
3. Yet Another Use For Green Tea Extract
4. Tomato Extract Found To Reduce The Risk Of Thrombosis
5. Slowing Cartilage Loss In Arthritis With Fruit Extracts
6. Extravagant Pay For Emergency Department Head Of Caboolture Hospital
7. High Blood Pressure Can Be Treated With Grape Seed Extract
8. Saw Palmetto Extract No Good In Improving Prostate Health
9. Greenpeace Says 93,000 Extra Cancer Deaths Due To Chernobyl Fallout
10. NHS To Take Extra Care Of The Aged
11. Western Australian Government Spending Extra For Mental Health Services
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... May 26, 2016 , ... ... strategic sales leadership and to further develop their rapidly expanding portfolio of customer ... Administration with a concentration in Marketing and an M.B.A. with concentration in management ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... surgical safety efforts for several years, and the efforts have paid off. ... efforts include new standards of care to enhance perioperative patient experiences and reduce ...
(Date:5/26/2016)... Vegas, NV (PRWEB) , ... May 26, 2016 , ... ... Ergonomic Tools,” identifies the impact of mobile devices on the billions of users, hundreds ... backs and necks. While not life threatening, the frequent and common action of ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... seeking nominations to serve on its Accreditation and Standards Committees and support ... quality-benchmarking activities incorporate key process and outcome measures, with the ultimate mission ...
(Date:5/26/2016)... ... May 26, 2016 , ... In 1980, Bill Howe opened ... throughout the beach community. His vision to grow the company was built on a ... maintain the highest level of training and customer service. Over 35 years later, Bill ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- FDA 510(k) clearance covers Confocal ... urological and surgical applications Mauna Kea ... the multidisciplinary confocal laser endomicroscopy (CLE) platform, today ... with the 12 th 510(k) clearance from ... new FDA clearance covers Confocal Miniprobes indicated for ...
(Date:5/25/2016)... Germany and GERMANTOWN, Maryland , ... QGEN ; Frankfurt Prime Standard: QIA) today announced ... agreement with Therawis Diagnostics GmbH to develop and commercialize predictive ... and market PITX2 as a marker to predict effectiveness of ... patients. "We are pleased to partner with Therawis, ...
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
Breaking Medicine Technology: